Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Accounts Payables (2020 - 2025)

Historic Accounts Payables for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $9.4 million.

  • MDxHealth's Accounts Payables fell 959.08% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year decrease of 959.08%. This contributed to the annual value of $8.0 million for FY2024, which is 919.31% down from last year.
  • As of Q3 2025, MDxHealth's Accounts Payables stood at $9.4 million, which was down 959.08% from $7.7 billion recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Accounts Payables registered a high of $7.7 billion during Q2 2025, and its lowest value of $7.5 million during Q4 2021.
  • Over the past 5 years, MDxHealth's median Accounts Payables value was $9.6 million (recorded in 2022), while the average stood at $555.6 million.
  • Per our database at Business Quant, MDxHealth's Accounts Payables tumbled by 2555.95% in 2023 and then skyrocketed by 6302056.74% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Accounts Payables stood at $7.5 million in 2021, then surged by 36.53% to $10.2 million in 2022, then dropped by 13.43% to $8.8 million in 2023, then decreased by 9.19% to $8.0 million in 2024, then rose by 17.35% to $9.4 million in 2025.
  • Its Accounts Payables was $9.4 million in Q3 2025, compared to $7.7 billion in Q2 2025 and $7.6 million in Q1 2025.